Hallucinations in Parkinson’s disease: new insights into mechanisms and treatments

Hallucinations are common in Parkinson’s disease and can be distressing to patients and their families. They are associated with higher rates of nursing home placement and with increased mortality. Their underlying mechanisms have been elusive, but recent advances in network imaging provides some in...

Descripción completa

Detalles Bibliográficos
Autores principales: Weil, Rimona S, Reeves, Suzanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116251/
https://www.ncbi.nlm.nih.gov/pubmed/33102741
http://dx.doi.org/10.47795/ONNS5189
_version_ 1783514206933352448
author Weil, Rimona S
Reeves, Suzanne
author_facet Weil, Rimona S
Reeves, Suzanne
author_sort Weil, Rimona S
collection PubMed
description Hallucinations are common in Parkinson’s disease and can be distressing to patients and their families. They are associated with higher rates of nursing home placement and with increased mortality. Their underlying mechanisms have been elusive, but recent advances in network imaging provides some intriguing insights into possible underlying drivers. Treatment is complicated by risk of worsening Parkinson’s motor symptoms and by higher rates of mortality with antipsychotics, but new therapeutic avenues are emerging that offer potential hope.
format Online
Article
Text
id pubmed-7116251
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-71162512020-10-23 Hallucinations in Parkinson’s disease: new insights into mechanisms and treatments Weil, Rimona S Reeves, Suzanne Adv Clin Neurosci Rehabil Article Hallucinations are common in Parkinson’s disease and can be distressing to patients and their families. They are associated with higher rates of nursing home placement and with increased mortality. Their underlying mechanisms have been elusive, but recent advances in network imaging provides some intriguing insights into possible underlying drivers. Treatment is complicated by risk of worsening Parkinson’s motor symptoms and by higher rates of mortality with antipsychotics, but new therapeutic avenues are emerging that offer potential hope. 2020-07-13 /pmc/articles/PMC7116251/ /pubmed/33102741 http://dx.doi.org/10.47795/ONNS5189 Text en http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms & conditions of the Creative Commons Attribution license http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Weil, Rimona S
Reeves, Suzanne
Hallucinations in Parkinson’s disease: new insights into mechanisms and treatments
title Hallucinations in Parkinson’s disease: new insights into mechanisms and treatments
title_full Hallucinations in Parkinson’s disease: new insights into mechanisms and treatments
title_fullStr Hallucinations in Parkinson’s disease: new insights into mechanisms and treatments
title_full_unstemmed Hallucinations in Parkinson’s disease: new insights into mechanisms and treatments
title_short Hallucinations in Parkinson’s disease: new insights into mechanisms and treatments
title_sort hallucinations in parkinson’s disease: new insights into mechanisms and treatments
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116251/
https://www.ncbi.nlm.nih.gov/pubmed/33102741
http://dx.doi.org/10.47795/ONNS5189
work_keys_str_mv AT weilrimonas hallucinationsinparkinsonsdiseasenewinsightsintomechanismsandtreatments
AT reevessuzanne hallucinationsinparkinsonsdiseasenewinsightsintomechanismsandtreatments

Ejemplares similares